Market

The summit provided an ideal platform for business experts and stakeholders from the country’s top 20 pharma companies

Dr Shailesh Ayyangar, Managing Director - India and Vice President - South Asia, - Sanofi India takes over as OPPI President

The summit provided an ideal platform for business experts and stakeholders from the country’s top 20 pharma companies

To make clinical R&D sector in India survive and grow, the government should become more practical in its approach while…

Asks sponsor to provide details of payment to investigators

Triples the production capacity for hormonal products

Are indicated for short-term treatment for healing and symptom relief of active duodenal ulcer

To treat colorectal and breast cancers

To develop a novel class of antibiotics, a new strategic therapeutic area for Debiopharm

To market CytoSorb, a‘first-in-class’ therapy for Sepsis management